Outcomes of deprescribing for people with life-limiting conditions: A systematic review
This systematic review suggests that deprescribing offers some benefits, including reduced medication burden and costs in people with life-limiting conditions. While there is no strong evidence for harm, a small proportion of patients reported increased risks, so careful monitoring is essential. Further research should explore how deprescribing outcomes vary by disease condition and medication type.
Authors
- David R. Sinclair (ORCID: https://orcid.org/0000-0002-3468-7475)
- A. Todd
- Liam Mullen (ORCID: https://orcid.org/0000-0002-4569-3264)
- Felicity Dewhurst (ORCID: https://orcid.org/0000-0001-9648-5329)
- Emily Shaw
- Rajeev Shrestha
Institutions
- Northumbria Healthcare NHS Foundation Trust (GB)
- NIHR Newcastle Biomedical Research Centre (GB)
- Newcastle University (GB)
Publication Details
- Journal
- Palliative Medicine
- Published
- 2026-02-22
- DOI
- https://doi.org/10.1177/02692163261416281
- Citations
- 1
- Primary Topic
- Pharmaceutical Practices and Patient Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 27.18